Latest Supply Agreements News

Beacon Minerals delivered steady gold output of 5,241 ounces in Q2 2026 at its Jaurdi Gold Project, alongside a fully franked cash dividend and a significant in-specie distribution of Forrestania Resources shares to shareholders.

BluGlass has landed a A$1.4 million Phase II deal with Uviquity, extending their collaboration on cutting-edge photonic integrated circuits and visible GaN lasers.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Advanced Engineered Materials has locked in an exclusive supply agreement with Swiss manufacturer Zürcher Frères, leveraging its nano particle high purity alumina to significantly enhance zirconia-alumina ceramics used in medical and industrial applications.

Cobram Estate Olives has wrapped up a smaller 2026 Australian olive harvest amid natural production cycles and flagged legal challenges over its California Olive Ranch acquisition, while integration efforts progress.

Lynas Rare Earths has deepened its footprint in Southeast Asia with a strategic A$50 million investment in JS Link’s new magnet factory in Malaysia, aiming to capture growth in automotive and renewable sectors.

Booster Wines Limited has proposed exiting its Hawke’s Bay vineyard and winery leases from the Private Land and Property Portfolio, offering a discounted convertible debt payment amid falling grape demand.

European Lithium and Critical Metals Corp. have amended their merger agreement, introducing a sale facility option for small shareholders and switching to direct share issuance, aiming for scheme implementation in October 2026.

Wide Open Agriculture is closing its German plant and pivoting to contract manufacturing in Asia to cut costs and scale lupin ingredient production efficiently under new CEO Craig Swan.

Iluka Resources has locked in a long-term supply deal with VHM Limited for rare earth concentrate from the Goschen project, underpinning its Eneabba refinery feedstock with a $40 million convertible note commitment to aid project development.

Clarity Pharmaceuticals will present compelling data at EANM 2026 demonstrating its 64Cu-SAR-bisPSMA imaging agent’s superior detection of prostate cancer recurrence and promising therapeutic results from 67Cu-SAR-bisPSMA in advanced disease.

Visionflex Group has landed a $0.8 million contract to supply clinical hardware for NSW Health’s statewide Remote Patient Monitoring Digital Uplift, reinforcing its role in virtual healthcare expansion.